| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Five9, Inc. | Director | Common Stock | 11.4K | $680K | $59.42 | May 21, 2024 | Direct |
| MapLight Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 25.6K | Oct 27, 2025 | Direct | ||
| MapLight Therapeutics, Inc. | Director | Voting Common Stock | 6.29K | Oct 27, 2025 | Direct | ||
| ForgeRock, Inc. | Director | Class A Common Stock | 0 | $23.25 | Aug 23, 2023 | Direct | |
| ForgeRock, Inc. | Director | Stock Option (right to buy) | 0 | $23.25 | Aug 23, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | Oct 27, 2025 | 2 | $0 | 4 | Oct 28, 2025 | Director |
| MPLT | MapLight Therapeutics, Inc. | Oct 25, 2025 | 0 | $0 | 3 | Oct 27, 2025 | Director |
| FIVN | Five9, Inc. | May 21, 2024 | 2 | $0 | 4 | May 22, 2024 | Director |
| FIVN | Five9, Inc. | May 21, 2024 | 0 | $0 | 3 | May 22, 2024 | Director |
| FORG | ForgeRock, Inc. | Aug 23, 2023 | 2 | -$4.15M | 4 | Aug 25, 2023 | Director |
| FORG | ForgeRock, Inc. | May 25, 2022 | 2 | $0 | 4 | May 27, 2022 | Director |
| MAAC | Montes Archimedes Acquisition Corp | Sep 30, 2021 | 0 | $0 | 4 | Oct 4, 2021 | Chief Financial Officer |
| FORG | ForgeRock, Inc. | Sep 20, 2021 | 2 | $0 | 4 | Sep 22, 2021 | Director |
| FORG | ForgeRock, Inc. | Sep 15, 2021 | 0 | $0 | 3 | Sep 15, 2021 | Director |